Cancer News: Myeloma
Relapsed refractory myeloma treatment outperformed standard therapy in a trial. The treatment is based on a newly approved immune modulator.
Genetic mutations related with multiple myeloma cells appear more complicated than thought before, perhaps affecting treatment strategies for this type of cancer.
An experimental drug known as dinaciclib could improve the effectiveness of certain multiple myeloma and myeloid leukemia therapies, according to a study.
A new study by researchers at Ohio State University provides evidence that genetically modifying immune cells might effectively treat multiple myeloma.